So our “maybe one” is officially “maybe two.” Sleuths also discovered Tisdale was conspicuously missing from the mom group’s ...
ARTBIO, Inc. ("ARTBIO"), a clinical-stage radiopharmaceutical company developing a new class of 212Pb alpha radioligand therapies (ARTs), announced the appointment of Jonathan Freeman, Ph.D. as Chief ...